Moneycontrol PRO
Upcoming Webinar:Moneycontrol Pro in association with Quants League Sep'21 Edition brings to you to 5-Days Live Algorithmic Options Trading Virtual Conference. Register Now!

Suven Life Sciences rises 1% on patent from Mexico and New Zealand

The new patents are corresponding to the new chemical entities for the treatment of disorders associated with Neurodegenerative diseases and patents are valid through 2030 and 2036 respectively.

August 07, 2018 / 11:17 AM IST
 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Shares of Suven Life Sciences rose 1.6 percent intraday Tuesday as company secured 1 patent each from Mexico and New Zealand.

The new patents are corresponding to the new chemical entities for the treatment of disorders associated with Neurodegenerative diseases and patents are valid through 2030 and 2036 respectively.

The granted claims of the patents include the class of selective H3 and 5-HT4 compounds respectively and are being developed as therapeutic agents for neurodegenerative disorders such as for the treatment of cognitive impairment associated with neurodegenerative disorders like Alzheimer’s disease, Attention deficient hyperactivity disorder (ADHD), Huntington’s disease, Parkinson and Schizophrenia and sleep disorders like Narcolepsy etc.

Venkat Jasti, CEO of Suven Life said, "We are very pleased by the grant of these patents to Suven for our pipeline of molecules in CNS arena that are being developed for cognitive disorders with high unmet medical need with huge market potential globally."

At 11:10 hrs Suven Life Sciences was quoting at Rs 226.20, up Rs 1.10, or 0.49 percent.

Close
Posted by Rakesh Patil
Moneycontrol News
first published: Aug 7, 2018 11:17 am

stay updated

Get Daily News on your Browser
Sections
ISO 27001 - BSI Assurance Mark